Cell and Gene Therapy Market Opportunity Assessment
Challenge: A multinational investment firm was interested in performing an objective, third party analysis of the cell and gene therapySuccessful Initial Licensing Meetings at BIO 2020
Situation: An emerging biotech desired to connect with potential partners to explore out licensing opportunities during BIO 2020. The client,2020 Q1 BCI – Fundamentals of Running a Biopharmaceutical
The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’sMarket Opportunity Assessment
Situation: An innovative preclinical CRO with multiple disruptive service offerings retained Kineticos to conduct an evaluation of each of their503B Compounding Pharmacy Market Assessment
Situation: A global biopharma company was interested in a comprehensive evaluation of the 503B compounding pharmacy market. The client wasPrimary Research Study
Kineticos conducted primary research via KOLs and an online survey to give our client qualitative and quantitative data to supportContract Development and Manufacturing Due Diligence
Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understandCompanion Diagnostics, Big Data, and New Approaches: How Does Neurosciences Catch Up to Oncology in Precision Medicine?
In September, we turn our focus onto Precision Medicine and its impact on the life sciences. Kineticos held 3 conversationsGo-to-Market Strategy and Tactical Deployment Plan
Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectivelyVoice of Customer Study
Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader